Acasti Pharma, Inc.
Acasti Pharma, Inc. (ACST) relating to its proposed merger with Grace Therapeutics, Inc. ACST shareholders are expected to own approximately 55% of the combined company.
Acasti Pharma, Inc. (ACST) relating to its proposed merger with Grace Therapeutics, Inc. ACST shareholders are expected to own approximately 55% of the combined company.
First Bancorp (FBNC) relating to its proposed merger with Select Bancorp, Inc. (SLCT). Under the terms of the agreement, SLCT shareholders will receive 0.408 shares of FBNC per share they own.
Motion Acquisition Corp. (MOTN) relating to its proposed merger with Ambulnz, Inc. MOTN will acquire Ambulnz, Inc. through a reverse merger, with Ambulnz, Inc. emerging as a publicly traded company.
Spartacus Acquisition Corp. (TMTS) relating to its proposed merger with NextNav. TMTS acquire NextNav through a reverse merger, with NextNav emerging as a publicly traded company.
Vector Acquisition Corp. (VACQ) relating to its proposed merger with Rocket Lab USA. VACQ acquire Rocket Lab through a reverse merger, with Rocket Lab emerging as a publicly traded company.
East Stone Acquisition Corp. (ESSC) relating to its proposed merger with JHD Holdings Limited. ESSC acquire JHD through a reverse merger, with JHD emerging as a publicly traded company.
Northern Genesis Acquisition Corp. II (NYSE: NGAB), relating to its 2021 merger with Embark Trucks, Inc., (Embark Technology, Inc. after the combination).
Lydall, Inc. (LDL) relating to its proposed acquisition by Unifrax. LDL shareholders will receive $62.10 in cash per share they own.
Raven Industries, Inc. (RAVN) relating to its proposed acquisition by CNH Industrial N.V. RAVN shareholders will receive $58.00 in cash per share they own.
New Senior Investment Group, Inc. (SNR) relating to its proposed merger with Ventas, Inc. SNR shareholders will receive 0.1561 shares of Ventas per share they own.